
Purple Mark Pharmaceuticals LLP
About Purple Mark Pharmaceuticals LLP
Data last updated:
Purple Mark Pharmaceuticals LLP is a limited liability partnership (LLP) based in Barwaha, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 April 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Gwalior, under LLPIN AAW-7273. Its GSTIN is 23ABAFP2862N1Z2 (Madhya Pradesh).
The LLP has a total obligation of contribution of βΉ50,000. It is led by designated partners Ravi Mewade and Ritesh Mewade.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Survey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India β 451115.
Company details
Contact details
Purple Mark Pharmaceuticals LLP's registered office is in Barwaha, Madhya Pradesh.
- Registered AddressSurvey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India β 451115
- IndustryChemicals, Manufacturing, Chemicals And Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Purple Mark Pharmaceuticals LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | |||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | |||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Purple Mark Pharmaceuticals LLP, buy the company report.
Designated partners of Purple Mark Pharmaceuticals LLP
Purple Mark Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Mewade | Designated Partner | 15 Apr 2021 | 5 Years 7 Months | Current |
| Ritesh Mewade | Designated Partner | 15 Apr 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Purple Mark Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Purple Mark Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Purple Mark Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABAFP2862N1Z2 | Madhya Pradesh | Active | 10 May 2021 |
To see the full GST registrations and return filing status of Purple Mark Pharmaceuticals LLP, buy the company report.
Recent activity
Purple Mark Pharmaceuticals LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Ravi Mewade was appointed as Designated Partner on 15 Apr 2021.
Frequently asked questions
Purple Mark Pharmaceuticals is an active limited liability partnership based in Barwaha, Madhya Pradesh, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 15 April 2021 (5+ years old) and is registered under LLPIN AAW-7273.
Purple Mark Pharmaceuticals has 2 current designated partners:
- Ravi Mewade - Designated Partner
- Ritesh Mewade - Designated Partner
The latest financial statements of Purple Mark Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Purple Mark Pharmaceuticals is 23ABAFP2862N1Z2, registered in Madhya Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Purple Mark Pharmaceuticals is AAW-7273. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Purple Mark Pharmaceuticals was incorporated on 15 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
Ravi Mewade was appointed as Designated Partner on 15 Apr 2021. Ritesh Mewade was appointed as Designated Partner on 15 Apr 2021.
The registered office of Purple Mark Pharmaceuticals is at Survey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India β 451115.
Purple Mark Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Purple Mark Pharmaceuticals can be reached at its registered office: Survey No. 126 Patwari Halka No 18 Block Gram Sirlay Teh. Barwaha, Madhya Pradesh, India β 451115.

